News

The grant will advance the development to further characterize a potent inhibitor of glycolysis targeting 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) in models of Glioblastoma Multiforme (GBM). ACT president and CEO

Study ALO-02-10-3001 included adult patients with moderate-to-severe chronic non-cancer pain lasting at least three months and requiring a continuous around-the-clock opioid analgesic for an extended period of time.

Actavis’ Diltiazem HCL capsules are generic equivalent of Valeant’s cardiovascular drug, Tiazac. Tiazac is a calcium ion cellular influx inhibitor which produces anti-hypertensive effect by relaxing vascular smooth

Under the agreement, urologists will be able to order Mitomics’ PCMT kit, through LabCorp’s specialized laboratory subsidiary, DIANON systems, which focuses on anatomic pathology, including uropathology. PCMT, which

Mylan said that following the settlement agreement, it is expected to get the rights to market Prednisolone sodium phosphate ODT product in the US on 1 April 2014,

RBCC CEO Patrick Brown said NuroPro has the potential to diagnose Parkinson’s disease early allowing physicians to initiate treatment regimens earlier, as well as conduct research of clinical-stage

The algenpantucel-L immunotherapy product candidate consists of a group of two allogeneic pancreatic cancer tumour cell lines that were modified to express Alpha-Gal. The open-label, multi-institutional study will

BiomarkerBase is an easy to use data container and provides quick access to the detailed information available about each biomarker. Using BiomarkerBase, biomarkers can be browsed by disease,

MedGenesis chairman and CEO Dr. Erich Mohr said the Deutsche Parkinson Vereinigung joined the alliance in support of GDNF program in Parkinson’s disease. "GDNF has the potential to